Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
KMTS Form 4 activity by transaction type, last 90 days
Form 4 transaction type
Transactions
Shares
Total value
Open-market sale
31
246,928
$6.00M
Grant or award
6
43,302
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
KMTS insider transactions (Form 4)
51
54 Form 4 filings on record, the earliest from Jul 17, 2025, newest first. Filing history page 1 of 2.
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $29.2800 to $29.2900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.2200 to $24.3200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.4240. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 9, 2027, subject to the Reporting Person's continued service through such date.
Footnote F1 (price, shares): The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.
Footnote F1 (price, shares): The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.5100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price, shares): The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.3500. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price, shares): The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.4300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price, shares): The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.9200 to $27.7700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.3100 to $26.3050. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.3150 to $26.3600. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9000 to $24.5700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9030 to $24.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.0000 to $25.3800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.8000 to $24.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.9000 to $24.8850. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9500 to $25.9300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.9500 to $26.0300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2696 to $23.2000. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1700 to $22.9000. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6600 to $24.2800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3300 to $23.0300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1600 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6400 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2400 to $23.1700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1700 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6500 to $24.2800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2524 to $23.1700. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.0577 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.6400 to $24.1100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F1 (shares): Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Footnote F1 (shares): Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Footnote F1 (shares): Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Footnote F1 (shares): Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Footnote F1 (shares): Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Footnote F3 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.45 to $22.44. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the… Full note on SEC EDGAR
Footnote F4 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.45 to $23.00. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the… Full note on SEC EDGAR
Footnote F5 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.49 to $24.10. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the… Full note on SEC EDGAR
Footnote F2 (price): In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026.
Footnote F2 (price): In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026.
Footnote F2 (price): The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.5400 to $21.3900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding… Full note on SEC EDGAR
Footnote F1 (shares): Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each… Full note on SEC EDGAR
Footnote F1 (shares): Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each… Full note on SEC EDGAR
Footnote F1 (shares): Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. ("Common Share"). Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3… Full note on SEC EDGAR
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) had 19 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for KMTS runs to 54 Form 4 filings, the earliest from 2025-07-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KMTS stock?
No insider purchases of KMTS were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling KMTS stock?
31 insider sales of KMTS were filed in the last 90 days, totaling $6.00M.
Where can I see KMTS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KMTS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Raymond W. Cohen - Director
Mary Kay Ladone - Director
